Your Input: | |||||
| ENSNMLP00000025384 | Superoxide dismutase 2, mitochondrial. (268 aa) | ||||
| ENSNMLP00000044260 | GTP binding protein overexpressed in skeletal muscle. (295 aa) | ||||
| ENSNMLP00000044246 | annotation not available (412 aa) | ||||
| ENSNMLP00000043844 | Insulin-like growth factor 1. (147 aa) | ||||
| ENSNMLP00000043811 | annotation not available (1188 aa) | ||||
| ENSNMLP00000043791 | Growth factor receptor-bound protein 2b. (219 aa) | ||||
| ENSNMLP00000043357 | annotation not available (359 aa) | ||||
| ENSNMLP00000043326 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha). (727 aa) | ||||
| ENSNMLP00000043305 | annotation not available (295 aa) | ||||
| ENSNMLP00000042694 | annotation not available (172 aa) | ||||
| ENSNMLP00000042679 | Cyclin-dependent kinase inhibitor 1D. (172 aa) | ||||
| ENSNMLP00000042050 | Insulin receptor a. (1364 aa) | ||||
| ENSNMLP00000041939 | Mitogen-activated protein kinase 9. (477 aa) | ||||
| ENSNMLP00000041870 | annotation not available (296 aa) | ||||
| ENSNMLP00000041857 | Mitogen-activated protein kinase 14b. (355 aa) | ||||
| ENSNMLP00000040968 | F-box protein 32. (357 aa) | ||||
| ENSNMLP00000040742 | Myosin IXb. (1484 aa) | ||||
| ENSNMLP00000040661 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit, a. (203 aa) | ||||
| ENSNMLP00000040653 | annotation not available (416 aa) | ||||
| GABARAPL2 | GABA type A receptor associated protein like 2. (123 aa) | ||||
| CCNB2 | Cyclin B2. (394 aa) | ||||
| ENSNMLP00000039849 | Raf-1 proto-oncogene, serine/threonine kinase a. (636 aa) | ||||
| ENSNMLP00000039784 | Polo-like kinase 2b (Drosophila). (654 aa) | ||||
| ENSNMLP00000039616 | GRB2 related adaptor protein 2a. (284 aa) | ||||
| GADD45B-2 | Growth arrest and DNA damage inducible beta. (158 aa) | ||||
| ENSNMLP00000039404 | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta. (1023 aa) | ||||
| ENSNMLP00000039206 | Mitogen-activated protein kinase 1. (399 aa) | ||||
| ENSNMLP00000039202 | Kruppel-like factor 2b. (365 aa) | ||||
| ENSNMLP00000038921 | SNAP associated protein. (130 aa) | ||||
| ENSNMLP00000038665 | GRB2 related adaptor protein a. (216 aa) | ||||
| ENSNMLP00000038659 | Growth arrest and DNA-damage-inducible, gamma a. (159 aa) | ||||
| ENSNMLP00000038286 | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta. (1042 aa) | ||||
| ENSNMLP00000037789 | Cyclin D1. (294 aa) | ||||
| ENSNMLP00000037330 | Cyclin-dependent kinase 2. (298 aa) | ||||
| ENSNMLP00000037219 | Protein kinase, AMP-activated, beta 1 non-catalytic subunit, b. (293 aa) | ||||
| ENSNMLP00000037208 | Protein kinase, AMP-activated, gamma 2 non-catalytic subunit b. (522 aa) | ||||
| ENSNMLP00000037150 | Forkhead box O1 a. (583 aa) | ||||
| ENSNMLP00000037063 | Protein kinase, AMP-activated, gamma 1 non-catalytic subunit. (345 aa) | ||||
| ENSNMLP00000036956 | Serum/glucocorticoid regulated kinase 2a. (363 aa) | ||||
| ENSNMLP00000036502 | V-akt murine thymoma viral oncogene homolog 1. (475 aa) | ||||
| CCNG2 | Cyclin G2. (361 aa) | ||||
| ENSNMLP00000036256 | Mitogen-activated protein kinase 12a. (361 aa) | ||||
| ENSNMLP00000035951 | Zgc:55558. (191 aa) | ||||
| ENSNMLP00000035941 | Insulin-like growth factor 1a receptor. (1386 aa) | ||||
| ENSNMLP00000035781 | Forkhead box O3b. (635 aa) | ||||
| ENSNMLP00000035743 | annotation not available (466 aa) | ||||
| ENSNMLP00000035595 | 3-phosphoinositide dependent protein kinase 1b. (531 aa) | ||||
| ENSNMLP00000035407 | Catalase. (558 aa) | ||||
| ENSNMLP00000035324 | Insulin receptor substrate 2a. (964 aa) | ||||
| ENSNMLP00000034676 | annotation not available (165 aa) | ||||
| HOMER2 | Homer scaffold protein 2. (371 aa) | ||||
| ENSNMLP00000033526 | annotation not available (345 aa) | ||||
| ENSNMLP00000033334 | annotation not available (290 aa) | ||||
| ENSNMLP00000033115 | RAS-like, family 11, member B. (235 aa) | ||||
| ENSNMLP00000032854 | Sphingosine-1-phosphate receptor 1. (368 aa) | ||||
| ENSNMLP00000032791 | Forkhead box O4. (496 aa) | ||||
| ENSNMLP00000032295 | Serum/glucocorticoid regulated kinase 1. (495 aa) | ||||
| ENSNMLP00000031914 | Transforming growth factor, beta 5. (418 aa) | ||||
| ENSNMLP00000031405 | Glucose-6-phosphatase a, catalytic subunit, tandem duplicate 2. (348 aa) | ||||
| ENSNMLP00000031353 | Glucose-6-phosphatase a, catalytic subunit, tandem duplicate 1. (355 aa) | ||||
| ENSNMLP00000030928 | Phosphoinositide-3-kinase, regulatory subunit 3a (gamma). (467 aa) | ||||
| ENSNMLP00000030808 | annotation not available (482 aa) | ||||
| ENSNMLP00000030371 | Insulin-like growth factor 1b receptor. (1399 aa) | ||||
| ENSNMLP00000029773 | Son of sevenless homolog 2 (Drosophila). (1314 aa) | ||||
| ENSNMLP00000029416 | annotation not available (692 aa) | ||||
| ENSNMLP00000028777 | GABA(A) receptor-associated protein b. (147 aa) | ||||
| ENSNMLP00000028707 | B-Raf proto-oncogene, serine/threonine kinase. (781 aa) | ||||
| ENSNMLP00000028651 | Insulin receptor b. (1305 aa) | ||||
| ENSNMLP00000028579 | Sphingosine-1-phosphate receptor 4. (352 aa) | ||||
| ENSNMLP00000028550 | annotation not available (520 aa) | ||||
| SMAD4 | SMAD family member 4. (480 aa) | ||||
| ENSNMLP00000027629 | Low density lipoprotein receptor class A domain containing 4b. (262 aa) | ||||
| ENSNMLP00000027578 | Forkhead box G1a. (270 aa) | ||||
| TGFBR2 | Transforming growth factor beta receptor 2. (535 aa) | ||||
| SLC2A4 | Solute carrier family 2 member 4. (510 aa) | ||||
| ENSNMLP00000026872 | annotation not available (479 aa) | ||||
| ENSNMLP00000026806 | annotation not available (71 aa) | ||||
| ENSNMLP00000026188 | Zgc:171775. (356 aa) | ||||
| ENSNMLP00000026149 | annotation not available (54 aa) | ||||
| ENSNMLP00000026148 | annotation not available (125 aa) | ||||
| ENSNMLP00000026118 | Mitogen-activated protein kinase 8a. (467 aa) | ||||
| ENSNMLP00000025967 | BCL6A transcription repressor a. (719 aa) | ||||
| ENSNMLP00000025931 | Serine/threonine kinase 11. (426 aa) | ||||
| ENSNMLP00000025379 | Si:ch211-195b13.1. (432 aa) | ||||
| ENSNMLP00000024882 | TNF superfamily member 10. (273 aa) | ||||
| ENSNMLP00000024843 | Solute carrier family 35 member E3. (313 aa) | ||||
| ENSNMLP00000024785 | annotation not available (494 aa) | ||||
| ENSNMLP00000024772 | MDM2 proto-oncogene. (499 aa) | ||||
| ENSNMLP00000024528 | annotation not available (433 aa) | ||||
| ENSNMLP00000023940 | SET domain containing 7, histone lysine methyltransferase. (368 aa) | ||||
| ENSNMLP00000023758 | annotation not available (480 aa) | ||||
| ENSNMLP00000023502 | Cyclin B3. (349 aa) | ||||
| ENSNMLP00000023238 | Mitogen-activated protein kinase 8b. (451 aa) | ||||
| ENSNMLP00000022828 | BCL2 interacting protein 3. (193 aa) | ||||
| ENSNMLP00000022673 | Mitogen-activated protein kinase 14a. (372 aa) | ||||
| CHUK | Component of inhibitor of nuclear factor kappa B kinase complex. (762 aa) | ||||
| ENSNMLP00000022497 | annotation not available (158 aa) | ||||
| ENSNMLP00000022495 | Growth arrest and DNA-damage-inducible, gamma b, tandem duplicate 1. (144 aa) | ||||
| ENSNMLP00000022442 | Cyclin B1. (375 aa) | ||||
| ENSNMLP00000022204 | Protein arginine methyltransferase 8b. (399 aa) | ||||
| ENSNMLP00000022136 | annotation not available (573 aa) | ||||
| ENSNMLP00000022030 | Mitogen-activated protein kinase 3. (394 aa) | ||||
| ENSNMLP00000021881 | Serum/glucocorticoid regulated kinase family member 3. (486 aa) | ||||
| ENSNMLP00000021613 | annotation not available (383 aa) | ||||
| ENSNMLP00000021554 | annotation not available (270 aa) | ||||
| ENSNMLP00000021522 | annotation not available (363 aa) | ||||
| ENSNMLP00000021386 | annotation not available (460 aa) | ||||
| ENSNMLP00000021180 | Nemo-like kinase, type 1. (411 aa) | ||||
| ENSNMLP00000021171 | annotation not available (288 aa) | ||||
| ENSNMLP00000021015 | Epidermal growth factor. (787 aa) | ||||
| ENSNMLP00000021001 | Forkhead box O6 b. (696 aa) | ||||
| ENSNMLP00000020863 | annotation not available (162 aa) | ||||
| ENSNMLP00000020661 | Insulin receptor substrate 2b. (983 aa) | ||||
| ENSNMLP00000020470 | BCL6B transcription repressor. (472 aa) | ||||
| ENSNMLP00000020375 | Protein kinase, AMP-activated, alpha 2 catalytic subunit. (579 aa) | ||||
| ENSNMLP00000020171 | Si:ch73-335l21.1. (442 aa) | ||||
| ENSNMLP00000020095 | Forkhead box O6 a. (567 aa) | ||||
| ENSNMLP00000019596 | Mitogen-activated protein kinase 12b. (364 aa) | ||||
| ENSNMLP00000019314 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial). (494 aa) | ||||
| ENSNMLP00000019256 | Growth arrest and DNA-damage-inducible, alpha, a. (190 aa) | ||||
| ENSNMLP00000018672 | Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4). (164 aa) | ||||
| ENSNMLP00000017936 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase. (440 aa) | ||||
| ENSNMLP00000017869 | annotation not available (740 aa) | ||||
| ENSNMLP00000017779 | Cyclin-dependent kinase inhibitor 1A. (166 aa) | ||||
| GADD45B | Growth arrest and DNA damage inducible beta. (165 aa) | ||||
| ENSNMLP00000017206 | Cyclin-dependent kinase inhibitor 2A/B (p15, inhibits CDK4). (122 aa) | ||||
| ENSNMLP00000017145 | Ring finger protein (C3H2C3 type) 6. (582 aa) | ||||
| ENSNMLP00000017006 | annotation not available (1168 aa) | ||||
| ENSNMLP00000016907 | annotation not available (374 aa) | ||||
| ENSNMLP00000016897 | Mitogen-activated protein kinase 11. (371 aa) | ||||
| ENSNMLP00000016757 | Transforming growth factor, beta 3. (401 aa) | ||||
| ENSNMLP00000016721 | annotation not available (325 aa) | ||||
| ENSNMLP00000016152 | annotation not available (294 aa) | ||||
| HRAS | HRas proto-oncogene, GTPase. (189 aa) | ||||
| ENSNMLP00000014598 | V-akt murine thymoma viral oncogene homolog 2. (482 aa) | ||||
| ENSNMLP00000014274 | annotation not available (448 aa) | ||||
| ENSNMLP00000014112 | Polo-like kinase 4 (Drosophila). (912 aa) | ||||
| ENSNMLP00000013999 | Nemo-like kinase, type 2. (519 aa) | ||||
| ENSNMLP00000013977 | Cyclin N-terminal domain containing 2. (314 aa) | ||||
| ENSNMLP00000013973 | Cyclin N-terminal domain containing 2. (308 aa) | ||||
| ENSNMLP00000013831 | Interleukin 10. (190 aa) | ||||
| ENSNMLP00000013714 | Mitogen-activated protein kinase 13. (362 aa) | ||||
| ENSNMLP00000013389 | annotation not available (1061 aa) | ||||
| ENSNMLP00000012808 | Transmembrane phosphatase with tensin homology. (511 aa) | ||||
| ENSNMLP00000012779 | Kruppel-like factor 4. (443 aa) | ||||
| PRMT8 | Protein arginine methyltransferase 8. (416 aa) | ||||
| ENSNMLP00000012094 | annotation not available (406 aa) | ||||
| ENSNMLP00000011957 | Mitogen-activated protein kinase kinase 2a. (401 aa) | ||||
| ENSNMLP00000011944 | Cyclin Dx. (315 aa) | ||||
| ENSNMLP00000011856 | Cyclin D2, a. (290 aa) | ||||
| ENSNMLP00000011793 | F-box protein 25. (358 aa) | ||||
| ENSNMLP00000011781 | BCL2 interacting protein 3 like b. (135 aa) | ||||
| ENSNMLP00000011650 | BCL6A transcription repressor b. (594 aa) | ||||
| ENSNMLP00000011641 | annotation not available (77 aa) | ||||
| FOXJ3 | Forkhead box J3. (595 aa) | ||||
| ENSNMLP00000010918 | Transforming growth factor, beta 2. (389 aa) | ||||
| ENSNMLP00000010671 | RasGEF domain family, member 1Bb. (428 aa) | ||||
| ENSNMLP00000010156 | Glucose 6 phosphatase, catalytic, 3. (334 aa) | ||||
| ENSNMLP00000009879 | Transforming growth factor beta receptor 2b. (540 aa) | ||||
| ENSNMLP00000009555 | Signal transducer and activator of transcription 3 (acute-phase response factor). (794 aa) | ||||
| ENSNMLP00000009456 | Recombination activating gene 2. (508 aa) | ||||
| ENSNMLP00000009454 | Recombination activating 1. (636 aa) | ||||
| ENSNMLP00000009428 | Protein arginine methyltransferase 3. (525 aa) | ||||
| ENSNMLP00000009376 | CD40 ligand. (238 aa) | ||||
| ENSNMLP00000008828 | Glutamate receptor, metabotropic 1a. (1129 aa) | ||||
| ENSNMLP00000008702 | Phosphoenolpyruvate carboxykinase 1 (soluble). (608 aa) | ||||
| ENSNMLP00000008700 | annotation not available (211 aa) | ||||
| ENSNMLP00000008623 | Inhibitor of nuclear factor kappa B kinase subunit beta. (741 aa) | ||||
| ENSNMLP00000008217 | A-Raf proto-oncogene, serine/threonine kinase. (554 aa) | ||||
| ENSNMLP00000007968 | V-akt murine thymoma viral oncogene homolog 3b. (502 aa) | ||||
| PLK1 | Polo like kinase 1. (596 aa) | ||||
| CSDE1 | Cold shock domain containing E1. (906 aa) | ||||
| ENSNMLP00000007480 | annotation not available (337 aa) | ||||
| ENSNMLP00000007030 | annotation not available (105 aa) | ||||
| KRAS | KRAS proto-oncogene, GTPase. (189 aa) | ||||
| ENSNMLP00000006840 | Phosphoinositide-3-kinase, regulatory subunit 2 (beta). (705 aa) | ||||
| ENSNMLP00000006639 | Polo-like kinase 3 (Drosophila). (552 aa) | ||||
| ENSNMLP00000006473 | V-akt murine thymoma viral oncogene homolog 3a. (499 aa) | ||||
| ENSNMLP00000005827 | ATG12 autophagy related 12 homolog (S. cerevisiae). (117 aa) | ||||
| ENSNMLP00000005814 | Protein kinase, AMP-activated, alpha 1 catalytic subunit. (575 aa) | ||||
| ENSNMLP00000005793 | annotation not available (224 aa) | ||||
| ENSNMLP00000005624 | Casein kinase 1, epsilon. (426 aa) | ||||
| ENSNMLP00000005495 | annotation not available (532 aa) | ||||
| ENSNMLP00000005340 | Zgc:92606. (116 aa) | ||||
| ENSNMLP00000005249 | annotation not available (584 aa) | ||||
| ENSNMLP00000005040 | Sirtuin 1. (659 aa) | ||||
| ENSNMLP00000004952 | Si:ch211-284e13.4. (1042 aa) | ||||
| AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2. (839 aa) | ||||
| ENSNMLP00000004564 | Protein arginine methyltransferase 1. (357 aa) | ||||
| ENSNMLP00000003728 | Si:dkey-101k6.5. (630 aa) | ||||
| ENSNMLP00000003393 | annotation not available (157 aa) | ||||
| ENSNMLP00000003313 | Zgc:73226. (189 aa) | ||||
| ENSNMLP00000002017 | annotation not available (771 aa) | ||||
| ENSNMLP00000001978 | Ras-related associated with diabetes. (309 aa) | ||||
| ENSNMLP00000001325 | Cyclin-dependent kinase inhibitor 1Bb. (176 aa) | ||||
| ENSNMLP00000001276 | Transforming growth factor, beta 3. (411 aa) | ||||
| ENSNMLP00000001213 | annotation not available (127 aa) | ||||
| ENSNMLP00000000637 | Mitogen-activated protein kinase 10. (216 aa) | ||||
| ENSNMLP00000000127 | Preproinsulin. (113 aa) | ||||